BioHarvest Sciences Inc. Common Stock (BHST) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.
The consensus price target is $10.00, representing an upside of 134.2% from the current price $4.27.
Analysts estimate Earnings Per Share (EPS) of $-0.78 and revenue of $0.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.80 vs est $-0.78 (missed -2.6%). 2025: actual $-0.60 vs est $-0.62 (beat +2.8%). Analyst accuracy: 97%.
BHST Stock — 12-Month Price Forecast
$10.00
▲ +134.19% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for BioHarvest Sciences Inc. Common Stock, the price target is $10.00.
The average price target represents a +134.19% change from the last price of $4.27.
BHST Analyst Ratings
Buy
Based on 1 analysts giving stock ratings to BioHarvest Sciences Inc. Common Stock in the past 3 months
EPS Estimates — BHST
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.80
vs Est –$0.78
▼ 2.5% off
2025
Actual –$0.60
vs Est –$0.62
▲ 2.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — BHST
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.025B
vs Est $0.025B
▲ 0.2% off
2025
Actual $0.035B
vs Est $0.035B
▼ 0.5% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
